Proteon logo     Print Page | Close Window

SEC Filings

10-Q
PROTEON THERAPEUTICS INC filed this Form 10-Q on 11/07/2017
Entire Document
 
 

SIGNATURES

 

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 7, 2017 PROTEON THERAPEUTICS, INC.  
       
  By: /s/ Timothy P. Noyes  
   

Timothy P. Noyes

President, Chief Executive Officer and Director

    (Principal Executive Officer)  
       
Date: November 7, 2017 By: /s/ George A. Eldridge  
   

George A. Eldridge

Senior Vice President, Chief Financial Officer,
Treasurer and Assistant Secretary

    (Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

60